Traditional Chinese Medicine-Derived Active Ingredient and Formulation Therapy for Glioma: Multi-Target Mechanisms, Drug Delivery Systems, and Advances in Clinical Translational Research
Xiaoting Shen, Yueling Wang, Yating Lin, Lirong Chen, Hao Wu, Jiaxin Jiang, Lisong Chen, Ying Chen, Desen Li, Wenyi Wang, Shuisheng Wu · 2026
Read Traditional Chinese Medicine-Derived Active Ingredient and Formulation Therapy for Glioma: Multi-Target Mechanisms, Drug Delivery Systems, and Advances in Clinical Translational Research by Xiaoting Shen, Yueling Wang, Yating Lin, Lirong Chen, Hao Wu, Jiaxin Jiang, Lisong Chen, Ying Chen, Desen Li, Wenyi Wang, Shuisheng Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13210432.txt.
Description
Shen leads a large team reviewing traditional Chinese medicine for glioma, in work from twenty twenty-six. Glioma is the most common and aggressive primary brain tumor. The blood brain barrier, tumor variety, and drug resistance make it hard to treat, with poor outlook.
Plant derived active ingredients act on many targets at once, a trait the authors value. They can trigger tumor cell death and boost other therapies. The review covers mechanisms, delivery systems that cross the brain barrier, and progress toward clinic use. It aims to show where this traditional source may add real options to modern brain tumor care.
Catalog record
| CREATOR | Xiaoting Shen, Yueling Wang, Yating Lin, Lirong Chen, Hao Wu, Jiaxin Jiang, Lisong Chen, Ying Chen, Desen Li, Wenyi Wang, Shuisheng Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |